Olivier du Mottay

Latham & Watkins a conseillé Samsung Medison, une société mondiale d'équipement médical et une filiale de Samsung Electronics, dans le cadre de la signature d’un accord définitif pour son acquisition de Sonio SAS, une société de logiciels d'intelligence artificielle pour l'échographie fœtale. La transaction est soumise à l’approbation des autorités compétentes. Associés à l'expertise de classe mondiale de Sonio en matière d'Intelligence artificielle, les systèmes d'échographie de pointe de Samsung Medison contribueront, à l'issue de la transaction, à mettre sur le marché des flux de travail améliorés par l'IA et à accélérer l'innovation en matière de résultats pour les patients et de qualité des soins prénatals. L'équipe Latham à Paris était menée par Olivier du Mottay, associé, avec les collaborateurs Jacek Urban et Eléonore Béthouart. Sont également intervenus sur les aspects droit de la santé, Eveline Van Keymeulen, associée, avec Jeanne Fabre ; sur les aspects droit social, Matthias Rubner, associé, avec Léo Theillac ; sur les aspects de contrats commerciaux et propriété intellectuelle, Jean-Luc Juhan, associé, avec Daniel Martel et Jean Bergeron, collaborateurs, ainsi qu'Alex Park, collaborateur à Singapour ; sur les aspects protection des données Myria Saarinen, associée, avec Charlotte Guérin ; sur les aspects finance, Michel Houdayer, associé, avec Léa Demulder ; sur les aspects investissements directs étrangers (FDI), Charles-Antoine Guelluy, associé, avec Christos Ierna.~~

May 24

1 min

Latham & Watkins has advised Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, on its agreement to acquire 100% of the shares of Sonio SAS, a fetal ultrasound AI software company. The transaction is subject to approval by the relevant authorities. Together with Sonio’s world-class AI expertise, Samsung Medison’s leading-edge ultrasound systems will help bring to market breakthrough AI-enhanced workflows and accelerate innovation in patient outcomes and quality of prenatal care. The Latham team in Paris was led by partner Olivier du Mottay, with Jacek Urban and Eléonore Béthouart. Advice was also provided on healthcare and life sciences matters by partner Eveline Van Keymeulen, with Jeanne Fabre; on employment matters by partner Matthias Rubner, with Léo Theillac; on IP and IT matters by partner Jean-Luc Juhan, with Daniel Martel and Jean Bergeron, and Singapore associate Alex Park; on data privacy matters by partner Myria Saarinen, with Charlotte Guérin; on finance matters by Paris partner Michel Houdayer, with Léa Demulder; and on foreign direct investment matters by partner Charles-Antoine Guelluy, with Christos Ierna.~~

May 24

1 min

Latham & Watkins a conseillé Bridgepoint dans le cadre de l'acquisition de LumApps auprès de ses actionnaires de référence Goldman Sachs Alternatives, Bpifrance, IRIS et Eurazeo Growth pour un montant de 650 000 000 USD afin de soutenir la société dans sa prochaine phase de croissance. Basée près de Lyon, en France, LumApps est une solution intranet sociale basée sur le cloud pour les entreprises, améliorant l'engagement et la productivité sur le lieu de travail en facilitant le travail, la communication et la collaboration des employés. Latham conseillait Bridgepoint avec une équipe menée par Olivier du Mottay et Simon Lange, associés, avec les collaborateurs Louise Gurly, Nicolas Lacour et Blaise Olympio. Sont également intervenus sur les aspects financement Lionel Dechmann et Carla-Sophie Imperadeiro, associés, avec Virginie Terzic, collaboratrice ; sur les aspects concurrence par Adrien Giraud, associé, avec Aliénor Estrade et Julia Malaussène ; et sur les aspects droit social Matthias Rubner, associé, avec Yanis Gaoua.~~

May 28

1 min

Latham & Watkins has advised Bridgepoint on entering into exclusive discussions with Nexity SA, a Euronext-listed real estate operator company, for the acquisition of its Residential Property Management Services Business, based on an enterprise value of €440 million. The transaction will also include a strategic partnership that aims to amplify existing synergies with Nexity’s activities. The acquisition remains subject to consultation with the relevant employee representative bodies and regulatory approvals. The Latham team was led by Paris partners Olivier du Mottay and Simon Lange, with associates Morgane Chaloin, Alexandre de Puysegur, and Giovanni Novi. Advice was also provided on commercial contracts and IP/IT matters by Paris partner Jean-Luc Juhan, with associate Jean Bergeron; on tax matters by Paris partner Olivia Rauch-Ravisé, with associate Jean-Baptiste Bourbier; and on antitrust matters by partner Adrien Giraud, with associates Mathilde Ayel and Julia Malaussène.~~

Jan 4

1 min

Bridgepoint has announced that Bridgepoint Europe VII (BE VII), a fund focused on investing in mid-market growth businesses, has made a strategic investment in RoC Skincare, the iconic skincare brand. RoC’s existing backer, Gryphon Investors, will sell its majority shareholding in RoC to Bridgepoint as part of the transaction. Financial terms were not disclosed. Latham & Watkins LLP advised Bridgepoint in the transaction with a corporate deal team led by New York partners David Allinson and Jane Greyf and Paris partner Olivier du Mottay, with associates Saïd Bakir, Sami El-Kebbi, Daniel Maggen, and Jee Yun (Jen) Oh. Advice was also provided on benefits matters by New York partner Bradd Williamson and Chicago counsel Leah Segall, with associate Victoria Wolfe; on finance matters by Washington, D.C. partner Jeffrey Chenard, with associate Kayla Van Wyngarden; on US tax matters by New York partner Eric Kamerman, with associate Ron Moore; on French tax matters by Paris partner Olivia Rauch-Ravisé, with associate Jean-Baptiste Bourbier; on IP matters by New York partner Steven Betensky, with associate Ryan Wilkins; on data privacy matters by Bay Area partner Robert Blamires, with associates Kathryn Parsons-Reponte and Dyllan Brown-Bramble; on FTC compliance matters by Washington, D.C. partner Jennifer Archie; on US antitrust matters by Bay Area partner Joshua Holian and Washington, D.C. counsel Joseph Simei, with associate Hanna Nunez Tse; on EU antitrust matters by Brussels/London partner David Little, with associates Oscar Hayward and James Mathieson; on EU healthcare regulatory matters by Paris/Brussels partner Eveline Van Keymeulen, with associates Jeanne Fabre and Ranulf Barman; on US healthcare regulatory matters by Washington, D.C. counsel Chad Jennings; on CFIUS matters by Washington, D.C. partner Jim Barker; and on insurance matters by Los Angeles partners Drew Levin and Harrison White, with associate Enrique Covarrubias.~~

Jan 23

1 min